JP2001501584A5 - - Google Patents

Download PDF

Info

Publication number
JP2001501584A5
JP2001501584A5 JP1997536327A JP53632797A JP2001501584A5 JP 2001501584 A5 JP2001501584 A5 JP 2001501584A5 JP 1997536327 A JP1997536327 A JP 1997536327A JP 53632797 A JP53632797 A JP 53632797A JP 2001501584 A5 JP2001501584 A5 JP 2001501584A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997536327A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001501584A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/005558 external-priority patent/WO1997037967A1/en
Publication of JP2001501584A publication Critical patent/JP2001501584A/ja
Publication of JP2001501584A5 publication Critical patent/JP2001501584A5/ja
Ceased legal-status Critical Current

Links

JP09536327A 1996-04-09 1997-04-04 カルシリチック化合物 Ceased JP2001501584A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62960896A 1996-04-09 1996-04-09
US08/629,608 1996-04-09
US3226396P 1996-12-03 1996-12-03
US60/032,263 1996-12-03
PCT/US1997/005558 WO1997037967A1 (en) 1996-04-09 1997-04-04 Calcilytic compounds

Publications (2)

Publication Number Publication Date
JP2001501584A JP2001501584A (ja) 2001-02-06
JP2001501584A5 true JP2001501584A5 (https=) 2005-01-13

Family

ID=26708193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09536327A Ceased JP2001501584A (ja) 1996-04-09 1997-04-04 カルシリチック化合物

Country Status (18)

Country Link
US (2) US6022894A (https=)
EP (1) EP0901459B1 (https=)
JP (1) JP2001501584A (https=)
CN (1) CN1254465C (https=)
AR (1) AR008586A1 (https=)
AT (1) ATE298739T1 (https=)
AU (1) AU726659B2 (https=)
BR (1) BR9708632A (https=)
CA (1) CA2251331C (https=)
CO (1) CO4820431A1 (https=)
DE (1) DE69733649T2 (https=)
EA (1) EA002984B1 (https=)
IL (1) IL126458A (https=)
NZ (1) NZ332068A (https=)
PL (1) PL191027B1 (https=)
SA (1) SA97180135B1 (https=)
SG (1) SG99290A1 (https=)
WO (1) WO1997037967A1 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US7202261B2 (en) * 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
UY24949A1 (es) * 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos
AU2351699A (en) * 1998-01-30 1999-08-16 Brigham And Women's Hospital The human calcium-sensing receptor in the detection and treatment of cancer
US7262280B1 (en) 1998-04-03 2007-08-28 Nps Pharmaceuticals, Inc. G-protein fusion receptors and constructs encoding same
PE20000415A1 (es) 1998-04-08 2000-05-21 Smithkline Beecham Corp Compuestos calciliticos
CA2245903A1 (en) 1998-09-28 2000-03-28 Mcgill University Use of pex in the treatment of metabolic bone diseases
PE20001456A1 (es) * 1999-02-02 2001-01-28 Smithkline Beecham Corp Compuestos calcioliticos
CO5180628A1 (es) * 1999-07-31 2002-07-30 Smithkline Beecham Corp Compuestos calcioliticos
US20030018203A1 (en) 2002-07-17 2003-01-23 Largo Maria Amparo Calcilytic compounds
AR030684A1 (es) * 2000-01-24 2003-09-03 Smithkline Beecham Corp Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
ES2296774T3 (es) * 2000-07-21 2008-05-01 Smithkline Beecham Corporation Compuestos calcioliticos.
FR2812875B1 (fr) 2000-08-08 2003-12-12 Centre Nat Rech Scient Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation
ATE411275T1 (de) 2000-08-11 2008-10-15 Japan Tobacco Inc Calciumrezeptor-antagonisten
ES2273909T3 (es) * 2000-10-25 2007-05-16 Smithkline Beecham Corporation Compuestos calciliticos.
MXPA04009959A (es) 2002-04-12 2004-12-13 Schering Corp Ligandos del receptor acoplado a la proteina g y metodos.
US6908935B2 (en) 2002-05-23 2005-06-21 Amgen Inc. Calcium receptor modulating agents
US7176322B2 (en) 2002-05-23 2007-02-13 Amgen Inc. Calcium receptor modulating agents
FR2847250B1 (fr) * 2002-11-15 2006-09-22 Oreal Composition, notamment cosmetique, comprenant une amine secondaire ou tertiaire
TWI316511B (en) 2002-11-26 2009-11-01 Smithkline Beecham Corp Calcilytic compounds
WO2004069793A2 (en) 2003-01-28 2004-08-19 Bristol-Myers Squibb Company Novel 2-substituted cyclic amines as calcium sensing receptor modulators
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
BRPI0407097A (pt) 2003-04-23 2006-01-24 Japan Tobacco Inc Antagonista do casr
US7265145B2 (en) * 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
EP1630157A4 (en) 2003-05-28 2007-05-23 Japan Tobacco Inc ANTAGONIST OF CASR
WO2005065050A2 (ja) 2003-12-25 2005-07-21 Asahi Kasei Pharma Corporation ２環化合物
JP2007523076A (ja) * 2004-02-06 2007-08-16 スミスクライン・ビーチャム・コーポレイション カルシウム受容体アンタゴニスト化合物
US7648965B2 (en) * 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US7531518B2 (en) 2004-05-14 2009-05-12 Unigene Laboratories Inc. Method for fostering bone formation and preservation
ES2561111T3 (es) 2004-05-28 2016-02-24 Mitsubishi Tanabe Pharma Corporation Arilalquilaminas y procedimiento para la producción de las mismas
US20080069814A1 (en) * 2005-01-05 2008-03-20 Novacea, Inc. Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof
US20090069276A1 (en) * 2005-04-22 2009-03-12 Novacea, Inc. Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
FR2885129B1 (fr) 2005-04-29 2007-06-15 Proskelia Sas Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation.
US20060293667A1 (en) * 2005-05-19 2006-12-28 Agnes Vignery Bone implant device and methods of using same
US8486381B2 (en) 2005-09-02 2013-07-16 Amgen Inc. Methods of modulating intestinal fluid balance
ATE450262T1 (de) 2005-11-25 2009-12-15 Galapagos Sas Harnstoff-derivate als calcium-rezeptor- modulatoren
WO2009055631A1 (en) * 2007-10-25 2009-04-30 Smithkline Beecham Corporation Calcilytic compounds
CN102056897B (zh) * 2008-06-05 2014-05-07 旭化成制药株式会社 磺酰胺化合物及其用途
EP2196461A1 (de) 2008-12-15 2010-06-16 Bayer CropScience AG 4-Amino-1,2,3-benzoxathiazin-Derivate als Pestizide
WO2010103429A1 (en) 2009-03-10 2010-09-16 Pfizer Inc. 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
CN103601645B (zh) * 2013-11-07 2016-05-25 上海适济生物科技有限公司 1-(苯乙基氨基)丙烷-2-醇类化合物或其盐的制备方法
WO2019153216A1 (zh) * 2018-02-09 2019-08-15 北京梅尔森医药技术开发有限公司 取代芳基胺醇化合物及其制备方法和用途
CN114746395A (zh) * 2019-12-05 2022-07-12 先正达农作物保护股份公司 用于制备苯基乙胺衍生物的一步方法
CN116199605A (zh) * 2023-02-27 2023-06-02 上海睿腾医药科技有限公司 一种5-氯-2-羟基-二甲基苯磺酰胺的合成方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE298506C (https=) *
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
GB1129072A (en) * 1966-02-01 1968-10-02 Ici Ltd Benzofuran and indole derivatives
GB1199037A (en) * 1967-09-27 1970-07-15 Ici Ltd Alkanolamine Derivatives
ES410417A1 (es) * 1973-01-08 1976-01-01 Andreu Sa Dr Procedimiento para la obtencion de aminoalcoholes derivadosdel p-acetamidofenol.
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
DE2530613A1 (de) * 1974-11-01 1976-05-06 Haessle Ab Aminderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives
JPS5936617B2 (ja) * 1976-03-05 1984-09-05 大塚製薬株式会社 カルボスチリル誘導体
CH619453A5 (https=) * 1976-03-17 1980-09-30 Otsuka Pharma Co Ltd
US4235919A (en) * 1977-07-21 1980-11-25 Sandoz Ltd. 1-(Indol-4-yloxy)-3-(2-substituted amino)-2-propanols and pharmaceutical use thereof
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
EP0002792A1 (en) * 1978-01-03 1979-07-11 Sandoz Ag 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
DK267779A (da) * 1978-06-27 1979-12-28 Merck & Co Inc Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
CH636856A5 (en) * 1978-07-17 1983-06-30 Sandoz Ag 4-(3-Aminopropoxy)indole derivatives, their preparation and medicines containing them
DE2914166A1 (de) * 1979-04-07 1980-10-23 Beiersdorf Ag Arylsubstituierte furane und verfahren zu ihrer herstellung
ES480066A1 (es) * 1979-04-28 1980-04-01 Especialid Latin Medicam Unive Procedimiento de obtencion de 1-4-cloro-&,&-dimetil-benceno-etanamino-2-oxi-3 ariloxi propanos.
DE2943406A1 (de) * 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols
DE2944222A1 (de) * 1979-11-02 1981-05-14 Basf Ag, 6700 Ludwigshafen Neue aminoderivate des 1,2-benzisothiazols
JPS568319A (en) * 1980-03-26 1981-01-28 Otsuka Pharmaceut Co Ltd Antihistamine
US4332787A (en) * 1980-06-23 1982-06-01 The Massachusetts General Hospital Assay for beta-adrenergic antagonists and antibody therefor
US4376125A (en) * 1980-11-05 1983-03-08 University Of Virginia Alumni Patents Foundation Aminobenzlpropranolol and pharmaceutical preparation thereof
JPS5780321A (en) * 1980-11-05 1982-05-19 Otsuka Pharmaceut Co Ltd Cardiotonic agent
EP0095454A3 (de) * 1982-05-13 1985-04-03 Gerot-Pharmazeutika Gesellschaft m.b.H. Neue kernsubstituierte Pyrogallol-Derivate
DE3301198A1 (de) * 1983-01-15 1984-07-19 Hoechst Ag, 6230 Frankfurt N-arylalkylamin-3-propoxypyridin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung
US4517188A (en) * 1983-05-09 1985-05-14 Mead Johnson & Company 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
ES8704873A1 (es) * 1985-01-15 1987-04-16 Glaxo Group Ltd Un procedimiento para la preparacion de 3,4-dihidroxifemetilamino derivados 2-ustituidos.
GB2192394A (en) * 1986-07-11 1988-01-13 Glaxo Group Ltd Amine derivatives
US5053514A (en) * 1988-08-10 1991-10-01 Otsuka Pharmaceutical Company, Limited Cardiotonics
DE4040186A1 (de) * 1989-12-20 1991-06-27 Hoechst Ag Hypoglykaemisch aktive propandiolaminderivate mit insulin-aehnlicher wirkung und deren verwendung, neue propandiolaminderivate, diese substanzen enthaltende pharmazeutische zubereitungen und ihre verwendung zur behandlung von krankheiten
DE4017019A1 (de) * 1990-05-26 1991-11-28 Hoechst Ag Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen
SG64322A1 (en) * 1991-05-10 1999-04-27 Rhone Poulenc Rorer Int Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
CN1192011C (zh) * 1991-08-23 2005-03-09 Nps药物有限公司 对钙受体具活性的芳烷基胺化合物
ATE313321T1 (de) * 1991-08-23 2006-01-15 Nps Pharma Inc Kalzium-rezeptor aktive verbindungen
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
DE69333527T2 (de) * 1993-02-23 2005-06-16 Brigham & Women's Hospital, Inc., Boston Calciumrezeptoraktive moleküle
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.

Similar Documents

Publication Publication Date Title
JP2000511435A5 (https=)
JP2002500524A5 (https=)
JP2000501018A5 (https=)
JP2002513297A5 (https=)
JP2001506266A5 (https=)
JP2000500076A5 (https=)
JP2000510894A5 (https=)
JP2002514124A5 (https=)
JP2000507053A5 (https=)
JP2000500055A5 (https=)
JP2000500026A5 (https=)
JP2000502472A5 (https=)
JP2000503406A5 (https=)
JP2000500874A5 (https=)
JP2000507474A5 (https=)
JP2001500365A5 (https=)
JP2000502425A5 (https=)
JP2000502485A5 (https=)
JP2000502568A5 (https=)
JP2001501584A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2001500930A5 (https=)
JP2000501876A5 (https=)
JP2000506195A5 (https=)